NEWS AND EVENTS

DIABIL-2 at the IDS congress 2015

The Immunology of Diabetes Society 14th International Congress took place in Munich on 12-16 April 2015. DIABIL-2 co-sponsored a session on Sunday 12th April: “Targeting a cytokine pathway”. http://www.ids2015.org/conference-programme.html

 

DIABIL-2 2nd Annual Meeting - 10 & 11 October 2014

DIABIL-2 partners gathered in Paris on 10th - 11th October 2014 for the 2nd Annual Meeting. This was also the occasion to bring together the clinical centres that are participating in the DIABIL-2 European trial to be launched in the coming months.

 

International Immunology of Diabetes Society meeting in Lorne (Australia) – 11 December 2013
Title: Low-dose IL-2 for treatment and prevention of Type 1 Diabetes – Session: regulation of the immune response (APHP) (D. Klatzmann Invited lecture) 

 

World Diabetes Congress meeting in Melbourne (Australia) – 6 December 2013

Title: Low-dose IL-2 for treatment and prevention type 1 diabetes – Session: type 1 diabetes (APHP) (D. Klatzmann Invited lecture)

 

American Diabetes Association meeting in Chicago (USA) – 22 June 2013

Title: Low Dose IL-2 Trial in Type 1 Diabetes – Session: Clinical Trials of T-Cell Therapeutics for Reversing Type 1 Diabetes (APHP) (D. Klatzmann Invited lecture)

 

DIABIL-2 1st general meeting - 12th and 13th November 2013, Basel

This meeting gathered all DIABIL-2 partners for presenting the progress made since the launch of the project a year ago as well as the next achievements for the forthcoming year. The meeting took place in the presence of members of the Independent Scientific Advisory Board of the project, who will carefully monitor and advise us in our activities.

 

JDRF meeting in New York - 19 October 2012

Presentation and discussion of the clinical results testing IL2 on Type 1 Diabetes patients (APHP, IT)

 

Launch of the DIABIL-2 project - 1st October 2012

The DIABIL-2 kick-off meeting will take place on November 7th and 6th, 2012 in France, near Paris.

The official launch event of the DIABIL-2 FP7 European Research Project will be hosted by the ‘Assistance Publique-Hôpitaux de Paris’, the organization which co-ordinates this European project.

This meeting gathered all DIABIL-2 partners for presenting and fine-tuning the planned DIABIL-2 work programme, in the presence of a representative from the European Commission and of the members of the Independent Scientific Advisory Board of the project, who will carefully monitor and advise us in our project activities.